aTyr Pharma Inc : LIFE

All LIFE Articles

26 Articles

Jon C. Ogg | Sep 25, 2012 at 8:05 AM EDT

Top Analyst Upgrades and Downgrades (ADP, BK, BWLD, EXPD, GPS, GE, GHDX, LIFE, MYGN, NKE, NOK, NTRS, P, PAYX, RHT, QCOR, SQNM, STT, TIVO, TOT, WAG)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday.…

Paul Ausick | Jul 2, 2012 at 4:07 PM EDT

24/7 Wall St. Closing Bell — July 2, 2012: A Mixed Monday on Wall Street

The three major US stock indexes opened only slightly higher this morning as European markets traded a little stronger today…

Jon C. Ogg | Jul 2, 2012 at 8:34 AM EDT

Top Analyst Upgrades & Downgrades (AFFX, BUD, ACI, CREE, DDS, DLTR, FINL, AWAY, IMAX, ITT, LH, LIFE, MAR, P, PSX, DGX, RIMM, TIF, SPY)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Monday.…

Jon C. Ogg | Jan 28, 2012 at 10:19 AM EST

24/7 Wall St. Top Analyst Calls of the Week (T, ADP. BBY, CHK, DNDN, ETFC, JCP, JPM, GS, MS, JEF, KLAC, LIFE, MCD, KORS, NFLX, VPRT, ZNGA)

Jon OggThis last week brought many new analyst calls in key stocks. At the end of each week we review…

Jon C. Ogg | Jan 26, 2012 at 8:04 AM EST

Top Analyst Upgrades & Downgrades (ADP, CHK, SCHW, GLW, ETFC, GD, GE, GMCR, NRGM, ITW, LRCX, LIFE, NFLX, NVDA, RYAAY, VALE)

Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms…

Jon C. Ogg | Jan 10, 2012 at 11:47 AM EST

The $1,000 Genome Finally Arrives (LIFE)

Personalized medicine is coming… if you can afford it. The quest for the $1,000 genomic map has been a race and…

Jon C. Ogg | Dec 28, 2011 at 7:01 AM EST

Top Biotech Stock Picks For 2012 (ARIA, DNDN, GILD, HGSI, ILMN, INCY, JAZZ, LIFE, THRX, IBB, XBI)

The biotech sector has seen its share of ups and downs in 2011 and prior years. It is almost always…

Jon C. Ogg | Aug 15, 2011 at 6:08 PM EDT

John Paulson’s Big Stock Changes (BAC, C, AEM, AU, COF, GFI, GRFS, JPM, LIFE, NYX, RAH, THC, WFC, GLD, NWSA)

Billionaire and hedge fund manager John Paulson of Paulson & Co. and of Paulson Management is a widely followed equity…

Jon C. Ogg | Jul 23, 2010 at 2:15 PM EDT

Looking at Genzyme’s Peers for ‘Other Buyout Candidate’ Probabilities (GENZ, SNY, GILD, CELG, BIIB, LIFE, HGSI, DNDN)

Genzyme Corporation (NASDAQ: GENZ) is flying high on reports that Sanofi-Aventis (NYSE: SNY) may have an interest in buying the…

Jon C. Ogg | Jul 14, 2010 at 8:06 AM EDT

Top Analyst Upgrades & Downgrades (ADCT, ALL, AMSC, BSX, CSIQ, ENOC, ITRI, JASO, KBH, LIFE, MDT, PLD, RYL, SHW, TSL, VVUS, YGE)

These are some of this Wednesday’s top analyst calls with upgrades, downgrades, and initiations seen from Wall Street firms: ADC…

Douglas A. McIntyre | Jul 29, 2009 at 9:09 AM EDT

Top Day Trader Alerts (ELRN, EXEL, LIFE, THQI, KG, BPSG, WCG, VPHM)

The following are some of the top stocks to watch for active trading today based on pre-market and after-hours volume…

1 2

aTyr Pharma Inc : LIFE

All LIFE Articles

Top Analyst Upgrades and Downgrades (ADP, BK, BWLD, EXPD, GPS, GE, GHDX, LIFE, MYGN, NKE, NOK, NTRS, P, PAYX, RHT, QCOR, SQNM, STT, TIVO, TOT, WAG)

24/7 Wall St. Closing Bell — July 2, 2012: A Mixed Monday on Wall Street

Top Analyst Upgrades & Downgrades (AFFX, BUD, ACI, CREE, DDS, DLTR, FINL, AWAY, IMAX, ITT, LH, LIFE, MAR, P, PSX, DGX, RIMM, TIF, SPY)

24/7 Wall St. Top Analyst Calls of the Week (T, ADP. BBY, CHK, DNDN, ETFC, JCP, JPM, GS, MS, JEF, KLAC, LIFE, MCD, KORS, NFLX, VPRT, ZNGA)

Top Analyst Upgrades & Downgrades (ADP, CHK, SCHW, GLW, ETFC, GD, GE, GMCR, NRGM, ITW, LRCX, LIFE, NFLX, NVDA, RYAAY, VALE)

The $1,000 Genome Finally Arrives (LIFE)

Top Biotech Stock Picks For 2012 (ARIA, DNDN, GILD, HGSI, ILMN, INCY, JAZZ, LIFE, THRX, IBB, XBI)

John Paulson’s Big Stock Changes (BAC, C, AEM, AU, COF, GFI, GRFS, JPM, LIFE, NYX, RAH, THC, WFC, GLD, NWSA)

Looking at Genzyme’s Peers for ‘Other Buyout Candidate’ Probabilities (GENZ, SNY, GILD, CELG, BIIB, LIFE, HGSI, DNDN)

Top Analyst Upgrades & Downgrades (ADCT, ALL, AMSC, BSX, CSIQ, ENOC, ITRI, JASO, KBH, LIFE, MDT, PLD, RYL, SHW, TSL, VVUS, YGE)

Top Day Trader Alerts (ELRN, EXEL, LIFE, THQI, KG, BPSG, WCG, VPHM)

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

aTyr Pharma Inc : LIFE

All LIFE Articles

Top Analyst Upgrades and Downgrades (ADP, BK, BWLD, EXPD, GPS, GE, GHDX, LIFE, MYGN, NKE, NOK, NTRS, P, PAYX, RHT, QCOR, SQNM, STT, TIVO, TOT, WAG)

24/7 Wall St. Closing Bell — July 2, 2012: A Mixed Monday on Wall Street

Top Analyst Upgrades & Downgrades (AFFX, BUD, ACI, CREE, DDS, DLTR, FINL, AWAY, IMAX, ITT, LH, LIFE, MAR, P, PSX, DGX, RIMM, TIF, SPY)

24/7 Wall St. Top Analyst Calls of the Week (T, ADP. BBY, CHK, DNDN, ETFC, JCP, JPM, GS, MS, JEF, KLAC, LIFE, MCD, KORS, NFLX, VPRT, ZNGA)

Top Analyst Upgrades & Downgrades (ADP, CHK, SCHW, GLW, ETFC, GD, GE, GMCR, NRGM, ITW, LRCX, LIFE, NFLX, NVDA, RYAAY, VALE)

The $1,000 Genome Finally Arrives (LIFE)

Top Biotech Stock Picks For 2012 (ARIA, DNDN, GILD, HGSI, ILMN, INCY, JAZZ, LIFE, THRX, IBB, XBI)

John Paulson’s Big Stock Changes (BAC, C, AEM, AU, COF, GFI, GRFS, JPM, LIFE, NYX, RAH, THC, WFC, GLD, NWSA)

Looking at Genzyme’s Peers for ‘Other Buyout Candidate’ Probabilities (GENZ, SNY, GILD, CELG, BIIB, LIFE, HGSI, DNDN)

Top Analyst Upgrades & Downgrades (ADCT, ALL, AMSC, BSX, CSIQ, ENOC, ITRI, JASO, KBH, LIFE, MDT, PLD, RYL, SHW, TSL, VVUS, YGE)

Top Day Trader Alerts (ELRN, EXEL, LIFE, THQI, KG, BPSG, WCG, VPHM)

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026